| 22-01-07 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 22-01-06 | Notification about results of final buy-back of shares | AQ |
| 21-12-30 | Notification about final share buy-back | AQ |
| 21-12-28 | Correction: Regarding results of a share buy-back offer | AQ |
| 21-12-28 | On substantial participation (4) - specified | AQ |
| 1 day | -0.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 2025-12-31 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 2009-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 2021-06-18 | |
Janis Buks
CHM | Chairman | - | 2022-08-31 |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.24% | -3.46% | - | - | 148M | |
| -0.81% | +0.87% | +22.41% | +72.77% | 49.06B | |
| -1.06% | -0.62% | +51.01% | +116.86% | 40.37B | |
| -0.97% | -0.61% | +14.75% | +86.17% | 12.19B | |
| -1.28% | -0.57% | -11.12% | +11.99% | 12.08B | |
| +0.57% | +0.95% | +29.02% | +153.11% | 9.14B | |
| +0.08% | -3.68% | +23.29% | +42.89% | 7.36B | |
| -0.04% | +0.85% | +28.15% | +224.81% | 7.35B | |
| -2.37% | -1.00% | +40.92% | -12.65% | 7.32B | |
| +0.03% | -1.75% | -40.80% | +14.39% | 5.19B | |
| Average | -0.61% | -0.27% | +17.51% | +78.93% | 16.67B | |
| Weighted average by Cap. | -0.82% | +0.37% | +26.23% | +85.52% |
Employees
2,191
Sector
Pharmaceuticals
